Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
Cited by 53
Related Papers
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
|Molecular Cancer|2021|2.2k
A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance
|Theranostics|2020|169
Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway
|Bioscience Reports|2018|133
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
|Journal for ImmunoTherapy of Cancer|2019|60
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy
|Cell Death and Disease|2024|18